Genelux | Investor Presentation Deck | 37 slides · page 15 of 37
The slide uses a cross-trial comparison to highlight the efficacy of Olvi-Vec in heavily pre-treated patients.
Pitch deck · key_takeaways · summarize · dense density
Slide locked Sign in to view
Slide schematic 6/6
callout 1/1 chart 1/1 list 1/1 source-note 1/1 table 1/1 title 1/1
Components 6
primary bar-grouped bullet source-note data headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1